Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Proactively manage your pharmacy inventory
Manage your formulary budget
Anticipate generic drug launch
Find generic entry opportunities
These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.
|Document Number||Estimated Expiration||Equivalent US Patent||US Expiry Date||Generic Name||US Applicant||US Tradename|
|313||► subscribe||5635485||Apr 1, 2018|
Sanofi Aventis Us
|248||► subscribe||6881200||Jun 11, 2016|
|248||► subscribe||5899880||May 4, 2016|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.